Doctors test 'Liquid Gold' inhaler to fight fatal lung scarring
NCT ID NCT07372989
Summary
This early-stage study is testing whether a mist made from donated human amniotic fluid is safe and might help people with interstitial lung disease (ILD), a condition that causes progressive scarring of the lungs. The trial will enroll 50 adults with ILD to inhale the experimental treatment and closely monitor them for side effects and any early signs of improved breathing. The main goal is to gather safety data to see if this approach is worth studying in larger future trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maule Stem Cell Research Institute
RECRUITINGVenice, Florida, 34292, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.